Clinical Trials Browser

Phase 2 × Recurrence × mocetinostat × Clear all

NCT00358982 2015-07-03

Study of MGCD0103 (MG-0103) in Patients With Relapsed or Refractory Hodgkin's Lymphoma

Phase 2 Terminated

Hodgkin Disease, Recurrence

NCT00359086 2015-07-01

Study of MGCD0103 Given Three Times Weekly in Patients With Relapsed and Refractory Lymphoma

Phase 2 Completed

Lymphoma, Recurrence